• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: receptor

  • Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer
    • in News
    • — 16 Mar, 2008

    Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer

    Robert Pirker
    Robert Pirker

    ROBERT PIRKER , Medical University of Vienna
    Phase III study results have detected improvements in overall survival among patients with advanced non-small cell lung cancer treated with a monoclonal antibody targeted to the epidermal growth factor receptor: EGFR.
    …
    Read more
    KRAS Mutation: Powerful Molecular Predictor of Cetuximab Response in Patients With Metastatic Colorectal Cancer
    • in Oncology
    • — 31 Aug, 2007

    KRAS Mutation: Powerful Molecular Predictor of Cetuximab Response in Patients With Metastatic Colorectal Cancer

    Pierre Laurent-Puig
    Pierre Laurent-Puig
    Bill Hait
    Bill Hait

    REFERENCE: ABSTRACT: 5671, American Association for Cancer Research, April 14-18, 2007, Los Angeles
    PIERRE LAURENT-PUIG, Hôpital Européen Georges Pompidou, Paris
    COMMENT: BILL HAIT, Johnson & Johnson, Raritan, NJ

    The presence of the KRAS mutation in tumor
    …
    Read more
  • Direct Renin Inhibitor Combined with Angiotensin Receptor Blockade Gives Additional Blood Pressure Lowering
    • in Cardiovascular
    • — 27 Mar, 2007

    Direct Renin Inhibitor Combined with Angiotensin Receptor Blockade Gives Additional Blood Pressure Lowering

    Suzanne Oparil

    SUZANNE OPARIL, University of Alabama, Birmingham

    REFERENCE: Abstract 405-12, American College of Cardiolgy New Orleans
    A combination of two antihypertensive agents has given improved blood pressure control in a study with nearly 2000 patients reported to the ACC meeting in
    …
    Read more
    Thrombin Receptor Antagonist: Advantages in Percutaneous Coronary Intervention?
    • in Cardiovascular
    • — 25 Mar, 2007

    Thrombin Receptor Antagonist: Advantages in Percutaneous Coronary Intervention?

    David Moliterno

    DAVID MOLITERNO, University of Kentucky, Lexington

    REFERENCE: American College of Cardiolgy New Orleans, March 24th Late Breaking Trials
    An oral thrombin receptor antagonist, SCH 530348 has proved safe and effective, and may be better than conventional anti-coagulation treatments for patients
    …
    Read more
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: receptor

© COPYRIGHT 2020 AUDIOMEDICA.COM.